| O2⋅− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate JD Schoenfeld, ZA Sibenaller, KA Mapuskar, BA Wagner, ... Cancer cell 31 (4), 487-500. e8, 2017 | 452 | 2017 |
| Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: the University of Iowa experience of two phase 1 … A Zahra, MA Fath, E Opat, KA Mapuskar, SK Bhatia, DC Ma, SNR Iii, ... Radiation research 187 (6), 743-754, 2017 | 153 | 2017 |
| The clinical significance of soluble PD-1 and PD-L1 in lung cancer TA Hejleh, M Furqan, Z Ballas, G Clamon Critical reviews in oncology/hematology 143, 148-152, 2019 | 76 | 2019 |
| A randomized phase II study of linsitinib (OSI-906) versus topotecan in patients with relapsed small-cell lung cancer AA Chiappori, GA Otterson, A Dowlati, AM Traynor, L Horn, TK Owonikoko, ... The oncologist 21 (10), 1163-1164e, 2016 | 52 | 2016 |
| Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer J Chau, M Yadav, B Liu, M Furqan, Q Dai, S Shahi, A Gupta, KN Mercer, ... BMC cancer 21, 1-14, 2021 | 47 | 2021 |
| Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers T Abu-Hejleh, JJ Mezhir, MJ Goodheart, TR Halfdanarson Current oncology reports 14, 277-284, 2012 | 47 | 2012 |
| SBRT to adrenal metastases provides high local control with minimal toxicity K Plichta, N Camden, M Furqan, TA Hejleh, GH Clamon, J Zhang, ... Advances in radiation oncology 2 (4), 581-587, 2017 | 43 | 2017 |
| Mitochondrial superoxide increases age-associated susceptibility of human dermal fibroblasts to radiation and chemotherapy KA Mapuskar, KH Flippo, JD Schoenfeld, DP Riley, S Strack, TA Hejleh, ... Cancer research 77 (18), 5054-5067, 2017 | 37 | 2017 |
| Chemotherapy use and surgical treatment by receptor subtype in node-negative T1a and T1b female breast cancers, Iowa SEER registry, 2010-to 2012 MC Schroeder, CF Lynch, T Abu-Hejleh, EA Chrischilles, A Thomas Clinical breast cancer 15 (1), e27-e34, 2015 | 26 | 2015 |
| Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients TA Hejleh, BR DeYoung, E Engelman, JM Deutsch, B Zimmerman, ... World journal of gastrointestinal oncology 4 (5), 103, 2012 | 26 | 2012 |
| Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer M Furqan, T Abu-Hejleh, LM Stephens, SM Hartwig, SL Mott, CF Pulliam, ... Redox biology 53, 102318, 2022 | 19 | 2022 |
| Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis M Furqan, YY Tien, MC Schroeder, KR Parekh, J Keech, BG Allen, ... Journal of thoracic disease 10 (10), 5850, 2018 | 19 | 2018 |
| Germline mutations predisposing to non-small cell lung cancer GH Clamon, AD Bossler, TA Hejleh, M Furqan Familial cancer 14, 463-469, 2015 | 17 | 2015 |
| The effect of receiving treatment within a clinical trial setting on survival and quality of care perception in advanced stage non–small cell lung cancer T Abu-Hejleh, EA Chrischilles, TR Halfdanarson, C Simon, JF Pendergast, ... American journal of clinical oncology 39 (2), 126-131, 2016 | 15 | 2016 |
| Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study MC Schroeder, CG Chapman, MC Nattinger, TR Halfdanarson, ... BMC health services research 16, 1-8, 2016 | 12 | 2016 |
| Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti–PD-L1 Immunotherapy Be Administered after Anti–PD-1–Related Immune Toxicities? U Swami, P Lenert, M Furqan, TA Hejleh, G Clamon, J Zhang Journal of thoracic oncology 13 (6), e102-e103, 2018 | 10 | 2018 |
| Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer MC Schroeder, YY Tien, K Wright, TR Halfdanarson, T Abu-Hejleh, ... Lung Cancer 95, 28-34, 2016 | 10 | 2016 |
| Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target D Safi, TA Hejleh, M Furqan Translational lung cancer research 10 (1), 462, 2021 | 9 | 2021 |
| Changing incidence of esophageal cancer among white women: analysis of SEER data (1992–2010) R Raman, S Deorah, BD McDowell, TA Hejleh, CF Lynch, A Gupta Contemporary Oncology/Współczesna Onkologia 19 (4), 338-340, 2015 | 9 | 2015 |
| The Prognostic and Diagnostic Value of [18F]FDG PET/CT in Untreated Laryngeal Carcinoma A Al-Ibraheem, AS Abdlkadir, D Al-Adhami, TA Hejleh, A Mansour, ... Journal of Clinical Medicine 12 (10), 3514, 2023 | 8 | 2023 |
